On the Record · Icon
Icon competitors, on the record
The companies Icon names as competitors in its annual reports, 2023 to 2025, and the companies that name Icon, each with the sentence and the filing.
Who Icon names
| Company | Named in |
|---|---|
| Fortrea | 2025 |
| IQVIA | 2025 |
| PAREXEL | 2025 |
| Syneos Health | 2025 |
| Thermo Fisher Scientific Inc. | 2025 |
In its own words
Fortrea, IQVIA, PAREXEL, Syneos Health, Thermo Fisher Scientific Inc.
Word for word“When competing for large development programs, ICON competes primarily with IQVIA, PAREXEL, the PPD clinical research services brand of Thermo Fisher Scientific Inc., Fortrea and Syneos Health.” 20-F for 2025
Who names Icon
Companies whose own annual reports name Icon as a competitor.
Word for word“Our major CRO competitors include IQVIA Holdings Inc., ICON plc, PPD, Inc. (now part of Thermo Fisher Scientific Inc.), Fortrea, Inc., and numerous specialty and regional CROs.” 10-K for 2025
Word for word“The primary competitors for our CRS business include QuintilesIMS, Laboratory Corporation of America, Pharmaceutical Product Development Inc., and Icon plc.” 10-K for 2017
Word for word“Our principal traditional CRO competitors are ICON plc, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, PAREXEL International Corporation, PPD, Inc., and Syneos Health, Inc.” 10-K for 2020
Word for word“Our Data and applications products also face competition from CROs, such as Fortrea, ICON, Syneos, PPD, and others, who provide data and clinical trial matching services to pharmaceutical and biotechnology companies.” 10-K for 2025
Read from Icon’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-05-27. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.